Watch Ticker

PolyPid Ltd. Ordinary Shares

Go to PolyPid Ltd. Ordinary Shares Website

$3.37

-0.07 (-2.03%)

Live

Previous Close

$3.44

Day Range

$3.3 - $3.5146

Previous Day Range

$3.31 - $3.6

Market Cap

$34.8 million USD

Day Vol.

123439

Previous Day Vol.

96272

Currency

USD

Primary Exchange

Nasdaq

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating man...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - PolyPid Secures $26.7 Million Through Warrant Exercise Following Successful SHIELD II Phase 3 Trial Results

PolyPid, a late-stage biopharma company, announced successful results from its Phase 3 SHIELD II trial for its lead product candidate D-PLEX100, which demonstrated a statistically significant reduction in surgical site infections. The company has secured additional funding of $26.7 million through the exercise of warrants, which is expected to extend its runway beyond the anticipated FDA approval of D-PLEX100.

Related tickers: PYPD.

Read Full Article

N/A - PolyPid to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

PolyPid, a late-stage biopharma company, announced that it will present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference on February 11-12, 2025. The company's lead product candidate, D-PLEX100, is in Phase 3 clinical trial for the prevention of abdominal colorectal surgical site infections.

Related tickers: PYPD.

Read Full Article

Trending Tickers

Please sign in to view